Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-25-230508

Options or other derivatives

  • Chief Medical Officer acquired 16,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Patel Naimish · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +16,500 16,500 D
Loading xslF345X05/ownership.xml…